The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application (TM99722736) for the mark 'Diabetes Reversal Alliance'. The application, filed on March 24, 2026, seeks to cover a range of medical services, including specialized diabetes treatment and prevention, telemedicine, wellness programs, health information dissemination, and diabetes screening.

This filing represents a new trademark application and does not impose immediate compliance obligations on regulated entities. However, it signals potential future branding and service offerings in the diabetes care sector. Compliance officers in healthcare and related fields should note this application as an indicator of market activity and potential future competitors or partners.